ImpediMed opens States-side
Wednesday, 18 June, 2008
Queensland Premier Anna Bligh opened Brisbane-based medical company ImpediMed's (ASX: IPD) US headquarters at BIO 2008 yesterday.
The new San Diego headquarters will take over the most of the manufacturing, customer training and technical service duties of the company.
However, the office in Brisbane will remain ImpediMed's head office, and will continue to be responsible for the financial and corporate development roles, as well as the company's clinical trials and research.
ImpediMed develops and sells medical devices, including a tool used to detect and assess lymphoedema, a disease commonly suffered by cancer patients, particularly those with breast cancer.
CTA granted for CAR-T cell therapy for multiple myeloma
The Therapeutic Goods Administration has granted Clinical Trial Approval for KMCAR T-cell...
2026 Snow Fellowship recipients to receive $24m in biomedical funding
Australian biomedical researchers Dr Deborah Burnett, A/Prof Sudarshini Ramanathan and Dr Ira...
$780m Sydney Biomedical Accelerator gains its founding Executive Director
Professor Victoria Cogger has been appointed as founding Executive Director of the Sydney...
